WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Apogee Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APGE annual revenue was $0.0, with N/A growth year-over-year.

APGE revenue history

Current Revenue
$0.0
Current Earnings
-$182.1M
Current Profit Margin
0%

Be the first to know when APGE announces revenue.

APGE Revenue History By Year

APGE Yearly RevenueAPGE RevenueAPGE ChangeAPGE Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Apogee Therapeutics Revenue FAQ

What was APGE's revenue last quarter?

Apogee Therapeutics (NASDAQ: APGE) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Apogee Therapeutics's revenue was $0.00.

What was Apogee Therapeutics's revenue in 2024?

Apogee Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Apogee Therapeutics make in a day?

Based on Apogee Therapeutics annual revenue for the past two years, APGE makes an average of $0.00 per day.

What was Apogee Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Apogee Therapeutics's revenue has grown null year over year. Apogee Therapeutics's revenue in the past year totaled $0.00.

How much does Apogee Therapeutics make in a year?

Apogee Therapeutics's revenue by year for the past two years is:
  • Apogee Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Apogee Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.